DK0815141T3 - Antistof mod et fusionspolypeptid omfattende en histidinandel - Google Patents

Antistof mod et fusionspolypeptid omfattende en histidinandel

Info

Publication number: DK0815141T3
Authority: DK; Denmark
Prior art keywords: antibody; fusion polypeptide; histidine moiety; histidine; moiety
Prior art date: 1995-03-01

Application number

DK96904728T

Other languages

English (en)

Inventor

Hanswalter Zentgraf

Claudia Tessmer

Iris Velhagen

Susanne Schwinn

Manfred Frey

Original Assignee

Deutsches Krebsforsch

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-01

Filing date

1996-03-01

Publication date

2002-01-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7755368&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0815141(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-03-01 Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch

2002-01-21 Application granted granted Critical

2002-01-21 Publication of DK0815141T3 publication Critical patent/DK0815141T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Virology (AREA)
Molecular Biology (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Hematology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK96904728T 1995-03-01 1996-03-01 Antistof mod et fusionspolypeptid omfattende en histidinandel DK0815141T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19507166A DE19507166C1 (de)	1995-03-01	1995-03-01	Antikörper gegen ein Histidin-Fusionspolypeptid, das einen Histidin-Anteil aufweist
PCT/DE1996/000369 WO1996026963A1 (de)	1995-03-01	1996-03-01	Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid

Publications (1)

Publication Number	Publication Date
DK0815141T3 true DK0815141T3 (da)	2002-01-21

Family

ID=7755368

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96904728T DK0815141T3 (da)	1995-03-01	1996-03-01	Antistof mod et fusionspolypeptid omfattende en histidinandel

Country Status (9)

Country	Link
US (3)	US6790940B1 (da)
EP (1)	EP0815141B2 (da)
JP (1)	JP3799059B2 (da)
AT (1)	ATE207935T1 (da)
CA (1)	CA2217186A1 (da)
DE (2)	DE19507166C1 (da)
DK (1)	DK0815141T3 (da)
ES (1)	ES2166878T3 (da)
WO (1)	WO1996026963A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19507166C1 (de)	1995-03-01	1996-04-18	Deutsches Krebsforsch	Antikörper gegen ein Histidin-Fusionspolypeptid, das einen Histidin-Anteil aufweist
DE19728697C1 (de) *	1997-07-04	1999-03-25	Deutsches Krebsforsch	Humaner Antikörper gegen ein Fusions(poly)peptid bzw. -protein, das einen Anteil von mindestens sechs Histidinen aufweist
US7794946B1 (en)	1998-02-04	2010-09-14	Life Technologies Corporation	Microarray and uses therefor
ATE283930T1 (de) *	1998-04-30	2004-12-15	Max Planck Gesellschaft	NEUE METHODE ZUR SELEKTION VON KLONEN EINER EXPRESSIONSBIBLIOTHEK MITTELS ßREARRAYINGß
US7294504B1 (en)	2001-12-27	2007-11-13	Allele Biotechnology & Pharmaceuticals, Inc.	Methods and compositions for DNA mediated gene silencing
EP2290107A1 (en)	2003-01-07	2011-03-02	Dyax Corporation	Kunitz domain library
US20040248323A1 (en)	2003-06-09	2004-12-09	Protometrix, Inc.	Methods for conducting assays for enzyme activity on protein microarrays
CN103314296A (zh)	2010-08-10	2013-09-18	安姆根有限公司	用于检测针对靶抗体的中和抗体的双功能体外靶结合测定
JP5849275B2 (ja) *	2011-07-11	2016-01-27	国立大学法人山口大学	抗ヒスチジンタグ抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5130416A (en) *	1986-08-13	1992-07-14	The United States Of America As Represented By The Department Of Health And Human Services	Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from plasmodium falciparum
EP0614531A1 (de) *	1992-09-30	1994-09-14	Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts	NACHWEISVERFAHREN FÜR p53-SPEZIFISCHE ANTIKÖRPER
DE4339533C2 (de)	1993-11-19	1997-07-03	Deutsches Krebsforsch	Nachweisverfahren für hdm-2 spezifische Antikörper
US5840834A (en) *	1994-12-21	1998-11-24	Virginia Commonwealth University	Technique for joining amino acid sequences and novel composition useful in immunoassays
DE19507166C1 (de)	1995-03-01	1996-04-18	Deutsches Krebsforsch	Antikörper gegen ein Histidin-Fusionspolypeptid, das einen Histidin-Anteil aufweist

1995
- 1995-03-01 DE DE19507166A patent/DE19507166C1/de not_active Expired - Lifetime
1996
- 1996-03-01 ES ES96904728T patent/ES2166878T3/es not_active Expired - Lifetime
- 1996-03-01 DK DK96904728T patent/DK0815141T3/da active
- 1996-03-01 EP EP96904728A patent/EP0815141B2/de not_active Expired - Lifetime
- 1996-03-01 DE DE59608073T patent/DE59608073D1/de not_active Expired - Fee Related
- 1996-03-01 AT AT96904728T patent/ATE207935T1/de not_active IP Right Cessation
- 1996-03-01 CA CA002217186A patent/CA2217186A1/en not_active Abandoned
- 1996-03-01 US US08/913,139 patent/US6790940B1/en not_active Expired - Lifetime
- 1996-03-01 WO PCT/DE1996/000369 patent/WO1996026963A1/de active IP Right Grant
- 1996-03-01 JP JP52521896A patent/JP3799059B2/ja not_active Expired - Lifetime
2003
- 2003-10-14 US US10/686,355 patent/US20040105854A1/en not_active Abandoned
2009
- 2009-05-14 US US12/465,855 patent/US7713712B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7713712B2 (en)	2010-05-11
US20090221040A1 (en)	2009-09-03
EP0815141B2 (de)	2009-02-25
WO1996026963A1 (de)	1996-09-06
ATE207935T1 (de)	2001-11-15
CA2217186A1 (en)	1996-09-06
EP0815141A1 (de)	1998-01-07
JP3799059B2 (ja)	2006-07-19
US6790940B1 (en)	2004-09-14
DE59608073D1 (de)	2001-12-06
EP0815141B1 (de)	2001-10-31
DE19507166C1 (de)	1996-04-18
JPH11510785A (ja)	1999-09-21
US20040105854A1 (en)	2004-06-03
ES2166878T3 (es)	2002-05-01

Publication	Publication Date	Title
DE68916973D1 (de)	1994-08-25	Anwendungssystem für arzneimittel enthaltende mikroemulsionen.
NO973123D0 (no)	1997-07-04	Direkte komprimerbare, höykonsentrerte acetaminofenpreparater
BR9810654B8 (pt)	2013-02-19	mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
FI973320L (fi)	1997-10-13	Kiinteitä aktiiviainetta sisältäviä valmisteita
GEP20105119B (en)	2010-11-25	Chimeric anti-cd20 antibody
DK0837927T3 (da)	2008-05-13	Anti-CD80-antistoffer
DK70789A (da)	1989-11-20	Anonymt, interaktivt telefonsystem
TR199600357A2 (tr)	1996-11-21	Rekombinant simanlik (Ob) proteinleri.
BR9504791B1 (pt)	2010-10-05	composto de polipeptìdeo e composição farmacêutica.
EA199800946A1 (ru)	1999-06-24	Концентрированный препарат антител
FI895821A0 (fi)	1989-12-05	Farmaceutiskt aktiva cns foereningar.
TR28984A (tr)	1997-08-06	Aktif elyaf ignesi.
DE69014498D1 (de)	1995-01-12	Hyposensibilisierende wirksame Substanz.
DE68912318D1 (de)	1994-02-24	Membranverpackung.
IT1199735B (it)	1988-12-30	Anticorpi monoclonali cross reattivi e cross-protettivi contro sierotipi di p.aeruginosa
TR199600358A2 (tr)	1996-11-21	-Adrenerjik agonistleri.
FI910265L (fi)	1991-07-19	Akustisk isolator.
DE58902438D1 (de)	1992-11-12	Verpackung fuer kleinteile.
DK0815141T3 (da)	2002-01-21	Antistof mod et fusionspolypeptid omfattende en histidinandel
MX9204131A (es)	1993-04-01	Proteina receptora de gp120.
DK0863991T3 (da)	2004-02-09	Antigeniske præparater
ES1006978Y (es)	1989-07-16	Dispositivo corrector nasal.
NO894895D0 (no)	1989-12-06	Flammehemmende preparater.
FI922720A0 (fi)	1992-06-12	Farmakologiskt aktiva amidkarboxylatderivat.
DE68916547D1 (de)	1994-08-04	Diffusionsversprüher für aerosol.